Molecular Testing in Thyroid Cancer
0 Vues
• 07/01/23
0
0
Intégrer
administrator
Les abonnés
Panelists R. Michael Tuttle, MD; Eric J. Sherman, MD; Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FAPC, FACE; and Frank Worden, MD, discuss the present day use of molecular testing for thyroid cancer, which, for now, is largely prognostic but not predictive.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires